“Adverse Effects and Adherence to Treatment of Rifampicin 4 months Vs Isoniazid 6 months for Latent Tuberculosis”. Swiss Medical Weekly 141, no. 3334 (August 15, 2011): w13240. Accessed October 13, 2025. https://smw.ch/index.php/smw/article/view/1333.